Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CASH FLOW FROM OPERATING ACTIVITIES
Net income	$ 4,696	$ 13,304	$ 2,322
Adjustments to reconcile net income to net cash from operating activities:
Discontinued operations, net	0	0	468
Depreciation, depletion and amortization of assets	6,865	6,926	8,447
Deferred income tax provision (benefit)	57	(1,644)	46
Other noncash charges (benefit) to income	(100)	(8)	229
Asset impairments and related items	209	0	304
Gain on sales of assets and other, net	(522)	(308)	(192)
Undistributed losses (earnings) from equity investments	144	(219)	(70)
Dry hole expense	299	84	125
Changes in operating assets and liabilities:
(Increase) decrease in receivables	1,088	(97)	(2,086)
Increase in inventories	(91)	(230)	(86)
Increase in other current assets	(13)	(335)	(119)
Increase (decrease) in accounts payable and accrued liabilities	(549)	(478)	865
Increase (decrease) in current domestic and foreign income taxes	225	(185)	0
Operating cash flow from continuing operations	12,308	16,810	10,253
Operating cash flow from discontinued operations, net of taxes	0	0	181
Net cash provided by operating activities	12,308	16,810	10,434
CASH FLOW FROM INVESTING ACTIVITIES
Capital expenditures	(6,270)	(4,497)	(2,870)
Change in capital accrual	25	147	97
Purchase of businesses, assets and equity investments, net	(713)	(990)	(431)
Proceeds from sale of assets and equity investments, net	448	584	1,624
Equity investments and other, net	(470)	(116)	406
Investing cash flow from continuing operations	(6,980)	(4,872)	(1,174)
Investing cash flow from discontinued operations	0	0	(79)
Net cash used by investing activities	(6,980)	(4,872)	(1,253)
CASH FLOW FROM FINANCING ACTIVITIES
Draws on receivables securitization facility	900	400	0
Payment of receivables securitization facility	(900)	(400)	0
Debt issuance costs	(46)	0	0
Payments of long-term debt, net	(22)	(9,484)	(6,834)
Redemption of preferred stock	(1,661)	0	0
Purchases of treasury stock	(1,798)	(3,099)	(8)
Cash dividends paid on common and preferred stock	(1,365)	(1,184)	(839)
Proceeds from issuance of common stock	135	293	31
Contribution from noncontrolling interest	100	0	0
Financing portion of net cash paid for derivative instruments	0	(111)	(834)
Other financing, net	(233)	(130)	(80)
Financing cash flow from continuing operations	(4,890)	(13,715)	(8,564)
Financing cash flow from discontinued operations	0	0	(8)
Net cash used by financing activities	(4,890)	(13,715)	(8,572)
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	438	(1,777)	609
Cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of year	1,026	2,803	2,194
Cash, cash equivalents, restricted cash and restricted cash equivalents — end of year	$ 1,464	$ 1,026	$ 2,803